Enquiries: 01305 251150

Updated 24 May 2022

The COVID-19 pandemic has demonstrated the impact of science in developing vaccines. The Research Department at the Trust have contributed to vaccine research. The team have contributed enormously to the RECOVERY trial which has resulted in treatments that significantly reduce deaths.

The team has also:

  • recruited patients into a heart failure trial (PARADIGM) which led to the first new heart failure therapy in twenty years and provided another treatment option for patients.
  • recruited to the largest ever prostate cancer treatment trial (STAMPEDE) which has changed the treatment for men with prostate cancer worldwide.
  • recruited into a breast cancer study (PERSEPHONE) which will inform the duration of treatment.
  • recruited into a renal dialysis study that resulted in a new phosphate binder being introduced
  • collected data on COVID-19 admissions for the CCP-UK Study.